CN1194673C - Anti-Virus arosol inhalation medicine liquid - Google Patents
Anti-Virus arosol inhalation medicine liquid Download PDFInfo
- Publication number
- CN1194673C CN1194673C CN 03128739 CN03128739A CN1194673C CN 1194673 C CN1194673 C CN 1194673C CN 03128739 CN03128739 CN 03128739 CN 03128739 A CN03128739 A CN 03128739A CN 1194673 C CN1194673 C CN 1194673C
- Authority
- CN
- China
- Prior art keywords
- virus
- viruses
- atomizing
- atomized
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims description 17
- 239000003814 drug Substances 0.000 title description 11
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 title 1
- 230000002155 anti-virotic effect Effects 0.000 title 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 21
- 239000000460 chlorine Substances 0.000 claims description 21
- 229910052801 chlorine Inorganic materials 0.000 claims description 21
- 238000010790 dilution Methods 0.000 claims description 7
- 239000012895 dilution Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000000249 desinfective effect Effects 0.000 claims description 2
- 241000700605 Viruses Species 0.000 abstract description 28
- 239000000645 desinfectant Substances 0.000 abstract description 28
- 210000002345 respiratory system Anatomy 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000001988 toxicity Effects 0.000 abstract description 7
- 231100000419 toxicity Toxicity 0.000 abstract description 7
- 230000002147 killing effect Effects 0.000 abstract description 5
- 210000004400 mucous membrane Anatomy 0.000 abstract description 4
- 210000004072 lung Anatomy 0.000 abstract description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 210000002865 immune cell Anatomy 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 18
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 15
- 241000545067 Venus Species 0.000 description 15
- 238000004659 sterilization and disinfection Methods 0.000 description 14
- 230000001954 sterilising effect Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004877 mucosa Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000003928 nasal cavity Anatomy 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 208000023504 respiratory system disease Diseases 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000031973 Conjunctivitis infective Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses atomized inhalation physic liquor for atomized inhalation machines, which is prepared in a mode that a disinfectant which is capable of directly killing viruses and has low toxicity and irritation for human bodies is diluted to a concentration, and the concentration has less damage to inner surface mucous membranes of people's respiratory systems and has effects on viruses. After the atomized inhalation physic liquor is atomized into small droplets to be sucked, pathogenic viruses on inner surface mucous membranes of respiratory systems can be effectively inhibited and killed, and the atomized inhalation physic liquor penetrates in the microcirculatory blood of lungs; accordingly, virus activity and toxicity are reduced in local blood to make immune cells easily kill one part of viruses in local areas in order that virus identification and immunization of the whole body can be favorably built.
Description
The atomizing suction medicinal liquid that technical field the present invention relates to atomize and sucks the machine use.
Background technology does not also have directly for the various diseases that causes of poison due to illness at present, and the oral and flow of infusate of kill virus is used for clinical, reason is that the granule of virus is more much smaller than other pathogen, so drag is big, more difficult killing, the medicine that it can be killed is all very big to the injury of human body.For the available antibiotics of pathogen such as antibacterial it is effectively killed, but antibiotics is invalid to virus.For the virus type disease, be mostly to play certain therapeutical effect indirectly by improving the medicine of body immunity.The medicinal liquid that present atomizing sucks is by the machine that atomizing sucks medical liquid atomizing to be become minimum droplet, breathes then to reach therapeutic purposes after sucking.Wherein be used for diluting human lung's trachea, intrabronchial sputum more, make the too dried condensed sticking expectorant that is difficult for discharging after dilution, be convenient to discharge, also there is the atomizing of the antibiotics of use to suck and plays certain local antiinflammation, but viral respiratory system disease is not had direct therapeutical effect.
Thereby summary of the invention the objective of the invention is to provide a kind of directly inhibition and kill virus treatment due to illness the disease that causes of poison be used to the medicinal liquid that atomizes and suck.
The medicine of known directly kill virus is all very big to the human injury at present, can not be used for oral and transfusion, just is used for disinfectant and uses.The characteristics of human respiratory are that it has and the extraneous inner surface mucosa that carries out gas exchange, and it is very limited sucking by atomizing that the medicinal liquid that arrives the inner surface mucosa is absorbed by the body.The repair ability of human body mucosal epithelium cell is generally all very strong, choose the suitable direct kill virus of energy to people's toxicity and the zest little disinfectant of all trying one's best, and being diluted to the most appropriate concentration is prepared, be to accomplish little prerequisite is tried one's best in assurance to respiratory system inner surface mucosa injury under, to reach directly killing and inhibitory action to virus.Do although it is so and can not directly the virus of inside of human body tissue be killed, but can directly kill, suppress the virus on the respiratory system inner surface mucosa, and the performance of the first symptoms of respiratory system disease just in time is on the pathological changes of these mucous membrane surfaces, so symptom is eased.On the other hand, lungs are internal organs of blood oxygen metabolism, and its blood microcirculation is very abundant.The medicinal liquid that atomizing sucks enters blood after more easily being absorbed by surface mucous.Even use the very low drug level can not kill virus, but as long as it can suppress and reduce the activity and the toxicity of sub-fraction virus in local zonule (pulmonary blood microcirculation zone), just can help immunocyte in the blood and more easily this fraction virus of this regional area be killed and engulfed, set up identification and immunity virus thereby help whole body.From immune angle,, just shortened the course of disease if can shorten time of immunologic process like this to the poison of newly catching an illness.For long-term incurable chronic disease after due to illness poison infects, as long as these Causative viruss can be with blood circulation to the microcirculatory regional area of pulmonary, because these viral sub-fractions are suppressed, just might activate the kill ability of the interior immunocyte of blood again to these viruses, form immunity, realize therapeutical effect.Analyze thus, in medication, drug level can be very low.For viral respiratory system disease critically ill patient; because the infection of virus, mucous the oozing out of inflammatory of causing the mucosa interior tissue covered mucous membrane surface; at certain phase, to a certain extent, also played the effect of protection for the stimulation of medicine and damage.From the characteristics of atomizing suction machine, it becomes minimum droplet by ultrasound wave with medical liquid atomizing, can be covered in the inner surface of respiratory system after the suction equably, so actual suction volume seldom.In the selection of medication, the disinfectant that selection toxicity is low, zest is little, the little virus function that goes out simultaneously of damage is strong is with regard to particular importance.
The various disinfectant that the specific embodiment contains effective chlorine all have the wide spectrum killing action to virus, and general toxicity is all lower, as long as make concentration dilution arrive suitable level, can be used for preparing atomizing and suck medicinal liquid.
" Venus disinfectant solution " that China produces is a kind of chlorine-containing disinfectant, has the very strong virus function that goes out, health and epidemic prevention department through the whole nation is detected, it can be with the most difficult hepatitis B virus of killing 100% deactivation in one minute, even have only at effective chlorine density under the concentration situation of 5/1000000ths (5PP), still have very strong disinfective action.Its disinfectant solution that is used for the sterilization of instruments type detects through acute toxicity testing, and toxicity is also lower than Sal.The main disinfection composition of this disinfectant solution is the hypochlorite ion.Because of this disinfectant solution is stronger alkalescence, suppressed unsettled hypochlorous generation, also just suppressed simultaneously the generation of elemental oxygen, the prescription effect of its uniqueness in addition, make that its disinfectant solution stability that is used for sterilization of instruments is extremely strong, so that depositing more than 8 years after the time, effective chlorine density does not descend yet.Easily decompose the disinfectant that discharges elemental oxygen with other and compare, its injury to human body just may be relative smaller with stimulation.According to above characteristics, use " Venus disinfectant solution " preparation atomizing inhalation liquor ratio safer, effective.
My toxicity acute conjunctivitis that suffers from a disease in 1993, be commonly called as pink eye disease, with various antibiotics medicament for the eyes all ineffective, the state of an illness constantly increases the weight of, so I with sterilization of instruments type " Venus disinfectant solution " thin up 200 times, eye drip then, every has dripped one, feel that very soon misery alleviates greatly, basic recovery from illness in second day.It is more much better than than " the Venus disinfectant solution " of other sterilization type because of the stability of concentration of the effective chlorine of considering it using sterilization of instruments type " Venus disinfectant solution ", so the effective chlorine density of preparation liquid is also grasped with regard to relatively good control.The effective chlorine density of sterilization of instruments type " Venus disinfectant solution " is 0.6%-1% (6000PP to 10000PP), thus the effective chlorine density of my eye drop 50/30/1000000ths to 1000000ths (30PP---50PP) between.I used 90 times of eye drips of sterilization of instruments type " Venus disinfectant solution " dilution again afterwards, still can bear, and effective chlorine density is between 110/67/1000000ths to 1000000ths (67PP-110PP).
Nineteen ninety-five, I was after having suffered from flu, splash into nasal cavity with behind 200 times of sterilization of instruments type " Venus disinfectant solution " thin ups, the state of an illness alleviates very soon, the course of disease shortens, change 400 times of thin ups later on again into, effective chlorine density is between 25/15/1000000ths to 1000000ths (15PP-25PP), and effect is also good.My father (time 85 years old year) when catching a cold, also gave him the collunarium chamber with the diluent that adds 400 times in water afterwards, and effect is also good, but he is longer a period of time after throwing off a cold, and nose is very dry, and this illustrates the old people, this concentration is some height still, and the blanking time of a medicine should be more longer.
I used 600 times of sterilization of instruments type " Venus disinfectant solution " thin ups in 2003, effective chlorine density is between 17/10ths/1000000ths to 1,000,000 (10PP-17PP), sucked one minute with the atomizing of atomizing inhalation machine, the very fast disappearance of the symptom that has some inkling of a cold, but second day one side nasal cavity is very dried, dryness in the nasal cavity transference cure after three days, illustrate that atomizing is drawn into the easier drying that causes of pulmonary, this point and eyes have very big difference, and are because respiratory system is the organ of gas exchange circulation, very easily dry.On the other hand, since the people is had significant reaction, illustrating more should have effect to virus.The concentration of inferring diluent thus also can further reduce, and to alleviate the damage to surface mucous, reduces the chance that causes secondary infection thus.For safety, the atomizing of preparation sucks medicinal liquid, change into 1200 times of sterilization of instruments type " Venus disinfectant solution " thin ups, be effective chlorine density 5/1000000ths to 8/1000000ths (5PP---8PP) between, atomizing sucked one minute, nose was still dry in second day, so according to circumstances, the concentration of effective chlorine also can further reduce to 1,000,000/(1PP).
" Venus disinfectant solution " is except containing time chlorion, also contain other multiple composition, sterilization of instruments type " Venus disinfectant solution " has also added some compositions that may not have the inhibition metal of disinfective action to get rusty for solving the metallic weapon problem of rustiness, do not get rid of the possibility of these compositions to the stimulation injury effect of respiratory tract surface mucous, so under the situation of the concentration that can better control effective chlorine, also can prepare with " Venus disinfectant solution " dilution of other sterilization type.
The composition of " Venus disinfectant solution " energy kill virus is the hypochlorite ion, and therefore atomizing suction medicinal liquid also can directly be prepared with the sodium hypochlorite dilution.
For safety, atomizing sucks medicinal liquid and with normal saline used disinfectant is diluted preparation, effective chlorine density with 1,000,000/to 6/1000000ths (1PP-6PP) for well, according to patient's concrete condition, concentration is improve suitably.
Also will control well the blanking time for atomization inspiration treatment, and the reparation fully of respiratory system inner surface mucosa approximately takes the time more than three days, thus generally once ill should make primary atomization and suck, if necessary, blanking time should more than three days better.
The time that atomizing sucks was controlled in one minute, and it is fixed that the concrete time also will come according to the intensity that the atomizing droplet forms.
After sucking antiviral atomizing suction medicinal liquid, should rationally replenish vitamin A in right amount, be beneficial to the reparation of respiratory system inner surface mucosal epithelium cell.
After sucking antiviral atomizing suction medicinal liquid,, should regularly do atomizing and suck with normal saline for preventing the drying of respiratory system inner surface mucosa.
The Venus disinfectant that embodiment uses is a chlorine-containing disinfectant, and its effective disinfection composition is an effective chlorine, therefore the invention is characterized in that it is formed by the chlorine-containing disinfecting dilution agent, the content of its effective chlorine is 1,000,000/and to 110/1000000ths (1PP-110PP).
Claims (1)
1, a kind of medicinal liquid that is used to atomize and sucks, the machine that sucks by atomizing is atomized into minimum droplet with it, as breathe sucking treatment, it is characterized in that it is formed by the chlorine-containing disinfecting dilution agent then, the content of its effective chlorine is 1,000,000/to 110/1000000ths.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03128739 CN1194673C (en) | 2003-05-07 | 2003-05-07 | Anti-Virus arosol inhalation medicine liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03128739 CN1194673C (en) | 2003-05-07 | 2003-05-07 | Anti-Virus arosol inhalation medicine liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1457770A CN1457770A (en) | 2003-11-26 |
| CN1194673C true CN1194673C (en) | 2005-03-30 |
Family
ID=29430461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03128739 Expired - Fee Related CN1194673C (en) | 2003-05-07 | 2003-05-07 | Anti-Virus arosol inhalation medicine liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1194673C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111419906A (en) * | 2020-03-04 | 2020-07-17 | 柳保来 | Medicament for treating neocoronary pneumonia |
| WO2022032468A1 (en) * | 2020-08-11 | 2022-02-17 | 黄志祥 | Device, method, and drug for anti-respiratory virus |
-
2003
- 2003-05-07 CN CN 03128739 patent/CN1194673C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1457770A (en) | 2003-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2399449T3 (en) | Pulmonary administration of an alpha-1 proteinase inhibitor | |
| US20200268656A1 (en) | Nebulized Ethanol for Internal Disinfecting and Improvement | |
| JP5892933B2 (en) | Gas mist inhaler | |
| WO2010098430A1 (en) | Gas mist inhaler | |
| WO2022038507A1 (en) | A solution for use in treating hypoxemia and potential asphyxiation | |
| CN111956660A (en) | Method for preventing and treating viral respiratory diseases by atomizing iodine-containing disinfectant | |
| WO2022111497A1 (en) | Application of iodine in preparation of drugs for preventing and treating respiratory tract infectious diseases | |
| US20230158063A1 (en) | Airway epithelial alkaline therapy to treat viral respiratory infection | |
| CN1194673C (en) | Anti-Virus arosol inhalation medicine liquid | |
| CN104940994B (en) | A kind of artificial schneiderian membrane and application thereof | |
| US20250332095A1 (en) | Methods for treating respiratory viral infections | |
| CN111973577A (en) | Method for preventing and treating viral pneumonia, viral influenza and common cold by using atomized alcohol | |
| RU2742505C1 (en) | Aerosol for invasive mechanical ventilation in covid-19 | |
| AU2021326382B2 (en) | Use of a heparin composition in the treatment of viral lung diseases, acute and/or chronic lung diseases by soft mist inhaler or vibration mesh technology nebulizer through inhalation route | |
| US7097852B1 (en) | Solution comprising sea water as expectorant and virucidal for the treatment of respiratory diseases and method to use and develop | |
| WO2022047188A1 (en) | Process of using chlorine dioxide for the attenuation and or treatment of coronavirus diseases | |
| WO2021203101A1 (en) | Hypochlorous acid solutions and methods of use | |
| Rahimi et al. | A comprehensive review of the use of Sodium Chloride (NaCl) in the development of the COVID-19 vaccine and medical applications | |
| CN115212290A (en) | Atomized inhalation type atomized liquid for preventing and treating virus infection and production method thereof | |
| JP2023520289A (en) | Iodinated compounds for treating respiratory pathogens | |
| WO2021222291A1 (en) | Pharmaceutical composition comprising chlorine dioxide for the treatment of covid-19 | |
| US20210401876A1 (en) | Pharmaceutical composition of chlorine for treatment of respiratory viral infection | |
| US11179415B1 (en) | Process of using chlorine dioxide for the attenuation and/or treatment of Coronavirus diseases such as COVID-19 and disabling, treating or attenuating the SARS CoV-2 virus, and its future infective variants | |
| PRIGAL | Studies with Medicated Aerosols: The Use of the Lungs as a Portal for the Introduction of Therapeutic Agents for Systemic Effect | |
| Gandhi | Povidone-iodine Hookah Therapy for the Treatment of Covid-19 and other Respiratory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 101300 Beijing city Shunyi District Feng Bo color pension south 25 building 4 unit 101 Patentee after: Su Xiaolin Address before: 100034 Beijing city Xicheng District West Fourth North Street No. 3 headlines Patentee before: Su Xiaolin |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050330 Termination date: 20140507 |